Лікарі за захворюванням Рак легенів в Китай — Сторінка 2

Є Сюньцзюнь — фахівець у Hainan Chengmei Hospital, який спеціалізується на робот-асистованій та лапароскопічній малоінвазивній хірургії пухлин сечовидільної системи. Він лікує рак нирки, уротеліальний рак та рак простати, використовуючи такі підходи, як органозберігаюча хірургія нирки, радикальна простатектомія з нервозберігаючою тактикою та ортотопічна неопластика сечового міхура. Його академічна активність включає участь у CUA Robotics Group та CSCO Renal/Urothelial Carcinoma Committee, а також роботу в редакційних групах з гайдлайнів.

Jian-Hua Fu is a specialist at Sun Yat-sen University Cancer Center, where he is Professor of thoracic cancers and Director of the Guangdong Esophageal Cancer Institute. He specializes in minimally invasive esophagectomy and minimally invasive thoracic surgery for esophageal cancer. His advanced training includes a 2002 specialization at Prince of Wales Hospital (CUHK) and lung transplantation study at Toronto General Hospital in 2004.

Huang Jinhua is a specialist at Sun Yat-sen University Cancer Center, working in Interventional Radiology with over 20 years of experience in minimally invasive cancer therapy. He performs interventional treatments such as transarterial chemoembolization and radiofrequency ablation for solid tumors. His long training path includes a Fellow period in Radiology and Interventional Radiology at the same cancer center (1988–1995).

Chen Likun is a specialist at Sun Yat-sen University Cancer Center, working in Medical Oncology as an Associate Professor. She focuses on lung cancer and esophageal cancer and participates in oncology leadership through CSCO and Guangdong anticancer committees. A concrete recognition is her 2008 “Ceclor Best Chinese Doctors” award.

Wei Wei is a specialist at Sun Yat-sen University Cancer Center, where he is Chief Physician and Assistant President in Liver Surgery. He focuses on liver cancer and hepatocellular carcinoma (HCC) and performs liver resection. His publications include hepatocellular carcinoma outcome studies in Br J Cancer (2014) and Med Oncol (2013).